{"id":757114,"date":"2023-05-10T06:03:36","date_gmt":"2023-05-10T10:03:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/"},"modified":"2023-05-10T06:03:36","modified_gmt":"2023-05-10T10:03:36","slug":"mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/","title":{"rendered":"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May  10, 2023  (GLOBE NEWSWIRE) &#8212; <strong>MannKind Corporation (Nasdaq: MNKD)<\/strong>, a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 2:05 pm (ET) at the InterContinental New York Barclay.<\/p>\n<p>Interested parties can access a link to the webcast from the News &amp; Events section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MHJCQvMxL6s--kfLU9M-yRod2rzKpCI6ZkxzvM9thYf5A4S_12mdAQQ8RstPC7A3-cq1P7HUp_A2jGa5e2EKImUU1XZmq_SJhnlNn9glGQHYNfw7mi4_-tKVU_jjG9UYOSFSStrbslovTMNYg-HNe8HYSMW8TJfTHcrpmZE9kwsXQdcbJWSkAYoADClNrX-OSXKz_kUlpO2aoZ7to7_6z_8iOf0wX0C2DjdpsSmnnsoccNx-1A4BHRnInN7Qy2M-I3dp7ks-xGq3ApnPustSCAgZPl71WLsKr9kwbPeM7PRtB-LdeuINYO3Jpb7jAOzsX6TupXJoKEHC8K6DzjcxDQ==\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a>. The webcast replay will remain available for 14 days following the live presentation.<\/p>\n<p>\n        <strong>About MannKind<\/strong>\n      <\/p>\n<p>MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases.<\/p>\n<p>We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies \u2013 dry-powder formulations and inhalation devices \u2013 offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation.<\/p>\n<p>With a passionate team of Mannitarians collaborating nationwide, we are on a mission to give people control of their health and the freedom to live life.<\/p>\n<p>Please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yxIao_fMxamkuHs02Cgp210MF9nCrqA4QZuLnaFhsHIkNv-UiNORc7bJoZ_gLOljxcf3Nl0scCOA-ruDIDRPuT7BrzgBTy2JEXql-StVrXY=\" rel=\"nofollow noopener\" target=\"_blank\">mannkindcorp.com<\/a> to learn more, and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O_SVuMpdOLA4eFcAqFf6ocKlFtDZoWvu9n7JgkXjV60mISBN1rel_Z06yfap7s4yTTqyH86KweqCXMpwB0-wBcLnr6HYJ4v8qCKW7yYd37bOLtW6KGVFUClIQ5BtooX_\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7Jz463xEcj7sQ2HSxoMKYFURiUfgDRVpx_T7CpJ2NkTzRRkU17ur9j7zJxp9oaNEu-njpkFjF4781FGGZwRCoFT0pWYwJ3ba7ltbm_dz3Zo=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=guAu6hW8WNnl4Lbn6beHkG6nInjvGLn9fMLpL2ocPL3ClZdWVs79jMygs9gO06ACu79rnkxy9oeQAgb9OKxoxA==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lkjx0EKOaio8I_S5JdGkotSIhirCu4pKLHXWjTTph5cUEkCC_rvktAqKAuDm5nUWWLVasogGxLq4YtU_a2H6QBfNTgfCyeojSWPA7a5GUqI=\" rel=\"nofollow noopener\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>MannKind Contact:<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Rose Alinaya, Investor Relations<br \/>(818) 661-5000<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TaF24udULGBfUfCM0fpiR3NulQ4ZDFu7ime35mMyQ5PRYKnwvSlUzO3bQ3gZJzoBHv5P4hzEvDI33mKZXa_7fnwYR93Bqmnz5IpJJZZLNmk=\" rel=\"nofollow noopener\" target=\"_blank\">ir@mannkindcorp.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODRmMTVhOWEtMDVhNi00NjZlLWE0MmItYjYyNzRmOWJlMmFkLTEwMTk2ODA=\/tiny\/MannKind.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 10, 2023 (GLOBE NEWSWIRE) &#8212; MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 2:05 pm (ET) at the InterContinental New York Barclay. Interested parties can access a link to the webcast from the News &amp; Events section of the Company\u2019s website at Events &amp; Presentations. The webcast replay will remain available for 14 days following the live presentation. About MannKind MannKind Corporation (Nasdaq: MNKD) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-757114","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 10, 2023 (GLOBE NEWSWIRE) &#8212; MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 2:05 pm (ET) at the InterContinental New York Barclay. Interested parties can access a link to the webcast from the News &amp; Events section of the Company\u2019s website at Events &amp; Presentations. The webcast replay will remain available for 14 days following the live presentation. About MannKind MannKind Corporation (Nasdaq: MNKD) &hellip; Continue reading &quot;MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-10T10:03:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference\",\"datePublished\":\"2023-05-10T10:03:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/\",\"name\":\"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=\",\"datePublished\":\"2023-05-10T10:03:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk","og_description":"DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 10, 2023 (GLOBE NEWSWIRE) &#8212; MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 2:05 pm (ET) at the InterContinental New York Barclay. Interested parties can access a link to the webcast from the News &amp; Events section of the Company\u2019s website at Events &amp; Presentations. The webcast replay will remain available for 14 days following the live presentation. About MannKind MannKind Corporation (Nasdaq: MNKD) &hellip; Continue reading \"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-10T10:03:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference","datePublished":"2023-05-10T10:03:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/","name":"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=","datePublished":"2023-05-10T10:03:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNDM0MSM1NTUzODQ4IzIwMDgxMDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mannkind-corporation-to-participate-in-the-2023-rbc-capital-markets-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/757114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=757114"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/757114\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=757114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=757114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=757114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}